| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/12/2001 | EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors |
| 12/12/2001 | EP1161419A1 Spirocyclic ketones and their use as tachykinin antagonists |
| 12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
| 12/12/2001 | EP1161412A1 Nuclear receptor arylating compounds |
| 12/12/2001 | EP1161410A1 Retinoid antagonists and use thereof |
| 12/12/2001 | EP1161266A1 Matriptase, a serine protease and its applications |
| 12/12/2001 | EP1161257A2 Pharmaceutical compositions comprising tgf-beta |
| 12/12/2001 | EP1161248A1 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia |
| 12/12/2001 | EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/12/2001 | EP1161235A1 Combinations for the treatment of diseases involving angiogenesis |
| 12/12/2001 | EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 12/12/2001 | EP1161150A1 Therapeutic antimicrobial compositions |
| 12/12/2001 | EP1161146A1 Deep penetrating antimicrobial compositions |
| 12/12/2001 | EP1032379B1 Composition with azelaic acid |
| 12/12/2001 | EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 12/12/2001 | EP0906077A4 Skin care compositions |
| 12/12/2001 | EP0828502B1 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
| 12/12/2001 | EP0730465B1 Use of angiotensin iii and analogs thereof in tissue repair |
| 12/12/2001 | EP0662946B2 Unsaturated aliphatic dicarboxylic acids |
| 12/12/2001 | EP0655921B1 Novel glucan preparation |
| 12/12/2001 | CN1326457A 4-aminopyrrolopyrimidines as kinase inhibitors |
| 12/12/2001 | CN1326456A 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives |
| 12/12/2001 | CN1326455A Improved chemical process and pharmaceutical formulation |
| 12/12/2001 | CN1326443A Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors |
| 12/12/2001 | CN1326441A 4-Aroyl-Piperidin-CCR-3 receptor antagonists III |
| 12/12/2001 | CN1326440A Piperdine CCR-3 receptor antagonists |
| 12/12/2001 | CN1326350A Fluticasone lotion having improved vasoconstrictor activity |
| 12/12/2001 | CN1325727A Liquid medicine for treating acne |
| 12/12/2001 | CN1325724A Burnt ointment and its preparing process |
| 12/12/2001 | CN1325698A Method for treating bacterial infection-type dermatopath and its preparing process and application |
| 12/11/2001 | US6329526 Cycloalkyl substituted imidazoles |
| 12/11/2001 | US6329517 Dermatomyositis-specific auto-antigen |
| 12/11/2001 | US6329511 Humanized mouse af2 immunoglobulin having specific amino acid sequences; treatment of autoimmune diseases |
| 12/11/2001 | US6329415 Aromatic heterocyclic compounds as antiinflammatory agents |
| 12/11/2001 | US6329413 Stable oil-in-water emulsion; anionic or nonionic hydrophilic, water soluble emulsifier; galactoarabinan, polygalactose, or polyarabinose; skin protectant |
| 12/11/2001 | US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 12/11/2001 | US6329397 Hydroxy pipecolate hydroxamic acid derivatives |
| 12/11/2001 | US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders |
| 12/11/2001 | US6329380 Pyrimidine benzimidizazole, pyrimidineimidazole or pyridine imidazole compounds for anticancer agents or atherosclerosis |
| 12/11/2001 | US6329365 Inhibitors of interleukin-1β converting enzyme |
| 12/11/2001 | US6329362 Modulation cell adhesion the compounds are able to inhibit the binding of alpha 4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders. |
| 12/11/2001 | US6329344 Urea derivative of alkylene dioxyfuran ethers |
| 12/11/2001 | US6328983 Cosmetics, skin treatments |
| 12/11/2001 | US6328978 Methods for the treatment of immunologically-mediated skin disorders |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/11/2001 | CA1341325C Triazole antifungal agents |
| 12/08/2001 | CA2349776A1 Novel crystalline forms of (3s-trans)-2-¬3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2h-1-benzopyran-7-yl|-4-(trifluoromethyl)-benzoic acid |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092526A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | WO2001092496A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | WO2001092492A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | WO2001092491A2 Mammalian protein phosphatases identified by in-silico analysis |
| 12/06/2001 | WO2001092333A2 Use of adnf for enhancing learning and memory |
| 12/06/2001 | WO2001092322A1 Use of collagen of aquatic origin for producing support designed for tissue engineering, and resulting supports and biomaterials |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092304A2 Transporters and ion channels |
| 12/06/2001 | WO2001092256A1 2,7-naphthyridine derivatives |
| 12/06/2001 | WO2001092253A2 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 12/06/2001 | WO2001092239A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/06/2001 | WO2001092230A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 12/06/2001 | WO2001092227A1 Chemical compounds |
| 12/06/2001 | WO2001092224A1 Indole derivatives with vascular damaging activity |
| 12/06/2001 | WO2001092221A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 12/06/2001 | WO2001092220A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 12/06/2001 | WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | WO2001092204A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 12/06/2001 | WO2001092202A1 Il-8 receptor antagonists |
| 12/06/2001 | WO2001091856A2 Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation |
| 12/06/2001 | WO2001091787A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | WO2001091780A1 Neuroprotective peptides |
| 12/06/2001 | WO2001091774A2 Method of treating chronic ulcers |
| 12/06/2001 | WO2001091773A2 Method of stimulating hair growth |
| 12/06/2001 | WO2001091736A2 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic |
| 12/06/2001 | WO2001091722A2 Water-thin emulsions with low emulsifier levels |
| 12/06/2001 | WO2001091713A1 Cosmetic composition comprising human serum albumin obtained from transgenic non-human animals |
| 12/06/2001 | WO2001091696A2 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 12/06/2001 | WO2001091682A1 Composition and applicator for topical substance delivery |
| 12/06/2001 | WO2001091588A1 Primary composition containing a lipophilic bioactive compound |
| 12/06/2001 | WO2001049673A3 Compounds and methods for modulation of estrogen receptors |
| 12/06/2001 | WO2001046392A3 Homologues of human heparanase and splice variants thereof |
| 12/06/2001 | WO2001045741A3 Methods for preparing pharmaceutical formulations |
| 12/06/2001 | WO2001041702A3 Zinc thiosalicylate, dermatological compositions containing same, in particular in the form of a self-adhesive device and method for preparing same |
| 12/06/2001 | WO2001021605A8 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds and use of said compounds in therapy, cosmetics and food |
| 12/06/2001 | WO2001019800A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 12/06/2001 | WO2001016345A3 Sequence-specific dna recombination in eukaryotic cells |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2001010847A8 Novel integrin receptor antagonists |
| 12/06/2001 | WO2000077018A3 Purine derivatives |
| 12/06/2001 | WO2000061750A3 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 12/06/2001 | US20010049386 Method of treating onychomycosis |
| 12/06/2001 | US20010049360 Betaglycan as an inhibin receptor and uses thereof |
| 12/06/2001 | US20010049355 Providing exogenous SLED to endothelial cells; maybe be provided systemically, topically, or via a vector comprising a SLED expression cassette |
| 12/06/2001 | US20010049349 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 12/06/2001 | US20010049106 ADAM (A Disintegrin And Metalloprotease) family of metalloproteases, and in addition contain thrombospondin domain (TS); treating diabetes, arthritis, cancer, solid tumors, autoimmune diseases |
| 12/06/2001 | US20010048917 Skin equivalent and methods of forming and using same |
| 12/06/2001 | US20010048915 Decreased endogenous nitric oxide activation |
| 12/06/2001 | DE10025464A1 Kombinierte Verwendung von Enzyminhibitoren zur Therapie von Autoimmunerkrankungen, bei Transplantationen und Tumorerkrankungen sowie Kombinationen von Enzyminhibitoren umfassende pharmazeutische Zubereitungen Combined use of enzyme inhibitors for the therapy of autoimmune diseases, transplantation and tumor diseases as well as combinations of enzyme inhibitors pharmaceutical preparations comprising |
| 12/06/2001 | CA2411655A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | CA2411323A1 Il-8 receptor antagonists |
| 12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |